Masterclass: Hypermobility and hypermobility related disorders. (February 2022) - Simmonds, J.V.
Abstract: Introduction: Hypermobile joints display a range of movement that is considered excessive, taking into consideration the age, gender and ethnic background of the individual. Joint hypermobility may present in a single joint, a few joints or in multiple joints and may be congenital or acquired with training, disease or injury. Hypermobile joints may be asymptomatic or may be associated with pain, fatigue, multisystemic complaints and significant disability. Furthermore, joint hypermobility may be a sign of an underlying hereditary disorder of connective tissue. Purpose: This masterclass aims to provides a state-of-the-art review of the aetiology, epidemiology, clinical presentation, assessment and management of joint hypermobility and hypermobility related disorders using an evidence based and biopsychosocial approach. The new framework for classifying the spectrum of joint hypermobility disorders along with new diagnostic criteria for the hypermobile Ehlers Danlos syndrome, published by an international consortium of clinical experts and researchers in 2017 is integrated into the paper. Implications for practice: People with joint hypermobility related disorders present to healthcare professionals with a wide range of symptoms which extend beyond the musculoskeletal system. Early recognition and treatment are key to effective management. A biopsychosocial and patient empowerment approach to functional restoration is recommended. Highlights: Joint hypermobility presents as a spectrum from asymptomatic through to syndromic symptomatic. Hypermobile Ehlers Danlos syndrome is the most common form of the Ehlers Danlos syndromes. Symptoms present across a spectrum from mild through to complex multisystemic symptoms. Early recognition and treatment of hypermobility related disorders is key to effective management. A biopsychosocial, empowerment model of functional rehabilitation is recommended.